STRS Ohio’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-51,000
Closed -$500K 2005
2023
Q4
$500K Sell
51,000
-9,500
-16% -$77.7K ﹤0.01% 1289
2023
Q3
$505K Sell
60,500
-29,700
-33% -$339K ﹤0.01% 1259
2023
Q2
$1.2M Sell
90,200
-1,900
-2% -$23.1K 0.01% 861
2023
Q1
$1.07M Buy
92,100
+64,700
+236% +$643K ﹤0.01% 908
2022
Q4
$224K Buy
27,400
+24,500
+845% +$211K ﹤0.01% 1565
2022
Q3
$16K Buy
+2,900
New +$16.6K ﹤0.01% 1944
2022
Q1
Sell
-13,200
Closed -$270K 2221
2021
Q4
$270K Sell
13,200
-7,400
-36% -$179K ﹤0.01% 1649
2021
Q3
$526K Sell
20,600
-13,400
-39% -$397K ﹤0.01% 1488
2021
Q2
$1.19M Sell
34,000
-31,100
-48% -$905K ﹤0.01% 1067
2021
Q1
$2.17M Sell
65,100
-6,700
-9% -$235K 0.01% 689
2020
Q4
$1.86M Sell
71,800
-16,000
-18% -$272K 0.01% 733
2020
Q3
$866K Buy
87,800
+62,500
+247% +$360K ﹤0.01% 998
2020
Q2
$87K Buy
+25,300
New +$86.1K ﹤0.01% 1819
2019
Q3
Sell
-47,300
Closed -$286K 2135
2019
Q2
$286K Buy
47,300
+3,300
+8% +$23.1K ﹤0.01% 1598
2019
Q1
$318K Hold
44,000
﹤0.01% 1519
2018
Q4
$325K Buy
+44,000
New +$279K ﹤0.01% 1471
2016
Q3
Sell
-18,200
Closed -$152K 1941
2016
Q2
$128K Sell
18,200
-26,000
-59% -$238K ﹤0.01% 1654
2016
Q1
$375K Sell
44,200
-2,900
-6% -$28.5K ﹤0.01% 1372
2015
Q4
$618K Sell
47,100
-109,900
-70% -$986K ﹤0.01% 1164
2015
Q3
$574K Buy
157,000
+21,300
+16% +$104K ﹤0.01% 1209
2015
Q2
$781K Buy
135,700
+6,400
+5% +$37K ﹤0.01% 1048
2015
Q1
$755K Buy
129,300
+78,657
+155% +$542K ﹤0.01% 976
2014
Q4
$397K Buy
50,643
+143
+0.3% +$915 ﹤0.01% 1267
2014
Q3
$248K Buy
50,500
+33,200
+192% +$174K ﹤0.01% 1413
2014
Q2
$107K Buy
17,300
+14,200
+458% +$71.1K ﹤0.01% 1541
2014
Q1
$17K Buy
+3,100
New +$19.6K ﹤0.01% 1685

Other funds holding PACB